Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).
|
Ann Rheum Dis
|
2013
|
3.25
|
2
|
Gout: an independent risk factor for all-cause and cardiovascular mortality.
|
Rheumatology (Oxford)
|
2009
|
2.08
|
3
|
Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
|
Arthritis Rheum
|
2002
|
1.54
|
4
|
Lipoteichoic acid induces HO-1 expression via the TLR2/MyD88/c-Src/NADPH oxidase pathway and Nrf2 in human tracheal smooth muscle cells.
|
J Immunol
|
2008
|
1.43
|
5
|
Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
|
J Cell Physiol
|
2007
|
1.34
|
6
|
Overexpression of HO-1 protects against TNF-alpha-mediated airway inflammation by down-regulation of TNFR1-dependent oxidative stress.
|
Am J Pathol
|
2009
|
1.25
|
7
|
Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality.
|
Rheumatology (Oxford)
|
2012
|
1.19
|
8
|
Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
|
J Cell Physiol
|
2006
|
1.14
|
9
|
Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: involvement of ERK, JNK, AP-1, and NF-kappaB.
|
J Cell Physiol
|
2010
|
1.13
|
10
|
Association of a transmembrane polymorphism of Fcgamma receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients.
|
Arthritis Rheum
|
2006
|
1.07
|
11
|
Involvement of p42/p44 MAPK, p38 MAPK, JNK, and NF-kappaB in IL-1beta-induced VCAM-1 expression in human tracheal smooth muscle cells.
|
Am J Physiol Lung Cell Mol Physiol
|
2004
|
1.07
|
12
|
Increased risk of cancer among gout patients: a nationwide population study.
|
Joint Bone Spine
|
2011
|
1.05
|
13
|
Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan.
|
Rheumatol Int
|
2012
|
1.02
|
14
|
IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells.
|
J Cell Physiol
|
2009
|
1.02
|
15
|
Risk of myocardial infarction among patients with gout: a nationwide population-based study.
|
Rheumatology (Oxford)
|
2012
|
1.00
|
16
|
Tumor necrosis factor-alpha enhances neutrophil adhesiveness: induction of vascular cell adhesion molecule-1 via activation of Akt and CaM kinase II and modifications of histone acetyltransferase and histone deacetylase 4 in human tracheal smooth muscle cells.
|
Mol Pharmacol
|
2008
|
0.99
|
17
|
Risk of end-stage renal disease associated with gout: a nationwide population study.
|
Arthritis Res Ther
|
2012
|
0.98
|
18
|
Cigarette smoke extract induces cytosolic phospholipase A2 expression via NADPH oxidase, MAPKs, AP-1, and NF-kappaB in human tracheal smooth muscle cells.
|
Free Radic Biol Med
|
2009
|
0.97
|
19
|
Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.
|
Clin Rheumatol
|
2011
|
0.96
|
20
|
Interstitial lung disease in polymyositis and dermatomyositis.
|
Clin Rheumatol
|
2009
|
0.96
|
21
|
Lipopolysaccharide induces VCAM-1 expression and neutrophil adhesion to human tracheal smooth muscle cells: involvement of Src/EGFR/PI3-K/Akt pathway.
|
Toxicol Appl Pharmacol
|
2007
|
0.95
|
22
|
Differential involvement of PKC-dependent MAPKs activation in lipopolysaccharide-induced AP-1 expression in human tracheal smooth muscle cells.
|
Cell Signal
|
2009
|
0.94
|
23
|
Involvement of MAPKs and NF-kappaB in LPS-induced VCAM-1 expression in human tracheal smooth muscle cells.
|
Cell Signal
|
2007
|
0.93
|
24
|
Infections in polymyositis and dermatomyositis: analysis of 192 cases.
|
Rheumatology (Oxford)
|
2010
|
0.91
|
25
|
Transactivation of Src, PDGF receptor, and Akt is involved in IL-1beta-induced ICAM-1 expression in A549 cells.
|
J Cell Physiol
|
2007
|
0.90
|
26
|
Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjögren's syndrome A/Ro antibody.
|
J Microbiol Immunol Infect
|
2005
|
0.89
|
27
|
Cigarette smoke extract induces COX-2 expression via a PKCalpha/c-Src/EGFR, PDGFR/PI3K/Akt/NF-kappaB pathway and p300 in tracheal smooth muscle cells.
|
Am J Physiol Lung Cell Mol Physiol
|
2009
|
0.88
|
28
|
Cytosolic phospholipase A2 induction and prostaglandin E2 release by interleukin-1β via the myeloid differentiation factor 88-dependent pathway and cooperation of p300, Akt, and NF-κB activity in human rheumatoid arthritis synovial fibroblasts.
|
Arthritis Rheum
|
2011
|
0.88
|
29
|
Elevated risk of mortality among gout patients: a comparison with the national population in Taiwan.
|
Joint Bone Spine
|
2011
|
0.87
|
30
|
Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study.
|
Rheumatology (Oxford)
|
2010
|
0.87
|
31
|
TLR4-dependent induction of vascular adhesion molecule-1 in rheumatoid arthritis synovial fibroblasts: Roles of cytosolic phospholipase A(2)alpha/cyclooxygenase-2.
|
J Cell Physiol
|
2010
|
0.86
|
32
|
CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells.
|
J Exp Clin Cancer Res
|
2008
|
0.84
|
33
|
Elevated serum homocysteine levels for gouty patients.
|
Clin Rheumatol
|
2004
|
0.83
|
34
|
CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs.
|
BMB Rep
|
2008
|
0.83
|
35
|
CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.
|
Mol Med
|
2012
|
0.82
|
36
|
Acetylsalicylic acid regulates MMP-2 activity and inhibits colorectal invasion of murine B16F0 melanoma cells in C57BL/6J mice: effects of prostaglandin F(2)alpha.
|
Biomed Pharmacother
|
2008
|
0.80
|
37
|
CAS Enhances Chemotherapeutic Drug-Induced p53 Accumulation and Apoptosis: Use of CAS for High-Sensitivity Anticancer Drug Screening.
|
Toxicol Mech Methods
|
2008
|
0.79
|
38
|
Major adverse cardiovascular events and mortality in systemic lupus erythematosus patients after successful delivery: a population-based study.
|
Am J Med Sci
|
2014
|
0.79
|
39
|
Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial.
|
Rheumatology (Oxford)
|
2013
|
0.78
|
40
|
Comparison of cryoglobulinemia in children and adults.
|
J Microbiol Immunol Infect
|
2012
|
0.78
|
41
|
Increased soluble CD4 in serum of rheumatoid arthritis patients is generated by matrix metalloproteinase (MMP)-like proteinases.
|
PLoS One
|
2013
|
0.78
|
42
|
Discontinuation of anti-TNF-α therapy in a Chinese cohort of patients with rheumatoid arthritis.
|
Clin Rheumatol
|
2012
|
0.78
|
43
|
Genetic variations in the C epsilon mX domain of human membrane-bound IgE.
|
Immunogenetics
|
2010
|
0.77
|
44
|
Better short-term clinical response to etanercept in Chinese than Caucasian patients with active ankylosing spondylitis.
|
Mod Rheumatol
|
2010
|
0.76
|
45
|
Vascular response of Raynaud's phenomenon to nifedipine or herbal medication (duhuo-tisheng tang with danggui-sini tang): a preliminary study.
|
Chang Gung Med J
|
2008
|
0.76
|
46
|
Coexisting ankylosing spondylitis and gouty arthritis.
|
Clin Rheumatol
|
2007
|
0.76
|
47
|
Survival impact of serum uric acid levels in children and adolescents.
|
Rheumatol Int
|
2013
|
0.75
|
48
|
Predictors of disability in Taiwanese patients with rheumatoid arthritis.
|
J Clin Nurs
|
2010
|
0.75
|